- Salary
- $180k – $230k/yr
- Location
- Remote
- Workplace
- Remote
- Type
- Full-time
- Department
- Capricor Therapeutics
- Seniority
- Director
- Education
- Master
- Source
- Lever
Description
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
The National Account Director will own payer access and coverage strategy for assigned national and regional commercial payers, PBMs, Medicaid plans, Medicare, and integrated delivery networks. This is a field-based role responsible for securing appropriate coverage and reimbursement for Deramiocel, Capricor's lead cell therapy for Duchenne muscular dystrophy. This individual will partner closely with Market Access leadership, Trade & Patient Services, Medical Affairs, HEOR, Sales, and Patient Advocacy to translate the Deramiocel value proposition into coverage decisions, medical policy positions that support timely, equitable patient access in a high-cost, rare-disease, medical-benefit market. The position will engage senior payer decision-makers, deliver compelling clinical and economic value stories, navigate medical-benefit dynamics unique to infused cell therapies, and feed payer intelligence back into Capricor's launch and access strategy.
Skills
ComplianceNegotiation
